346 related articles for article (PubMed ID: 33172177)
1. Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Owari T; Sasaki T; Fujii K; Fujiwara-Tani R; Kishi S; Mori S; Mori T; Goto K; Kawahara I; Nakai Y; Miyake M; Luo Y; Tanaka N; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172177
[TBL] [Abstract][Full Text] [Related]
2. Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.
Shang X; Lin X; Howell SB
Cell Commun Signal; 2014 Oct; 12():59. PubMed ID: 25344320
[TBL] [Abstract][Full Text] [Related]
3. Role of
Fujiwara-Tani R; Fujii K; Mori S; Kishi S; Sasaki T; Ohmori H; Nakashima C; Kawahara I; Nishiguchi Y; Mori T; Sho M; Kondoh M; Luo Y; Kuniyasu H
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481659
[TBL] [Abstract][Full Text] [Related]
4. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
5. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
Fujiwara-Tani R; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Kondoh M; Kuniyasu H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982569
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
Lin X; Shang X; Manorek G; Howell SB
PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
[TBL] [Abstract][Full Text] [Related]
7. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability.
Tanaka M; Kamata R; Sakai R
J Biol Chem; 2005 Dec; 280(51):42375-82. PubMed ID: 16236711
[TBL] [Abstract][Full Text] [Related]
8. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma.
Kwon MJ; Kim SH; Jeong HM; Jung HS; Kim SS; Lee JE; Gye MC; Erkin OC; Koh SS; Choi YL; Park CK; Shin YK
Lab Invest; 2011 Nov; 91(11):1652-67. PubMed ID: 21844869
[TBL] [Abstract][Full Text] [Related]
9. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.
Zhou N; Zhao WD; Liu DX; Liang Y; Fang WG; Li B; Chen YH
Microvasc Res; 2011 Sep; 82(2):113-21. PubMed ID: 21726568
[TBL] [Abstract][Full Text] [Related]
11. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of
Maesaka F; Kuwada M; Horii S; Kishi S; Fujiwara-Tani R; Mori S; Fujii K; Mori T; Ohmori H; Owari T; Miyake M; Nakai Y; Tanaka N; Bhawal UK; Luo Y; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742959
[TBL] [Abstract][Full Text] [Related]
13. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Shang X; Lin X; Alvarez E; Manorek G; Howell SB
Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
[TBL] [Abstract][Full Text] [Related]
14. Targeting claudin-4 enhances chemosensitivity in breast cancer.
Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H
Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991
[TBL] [Abstract][Full Text] [Related]
15. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.
Murakami-Nishimagi Y; Sugimoto K; Kobayashi M; Tachibana K; Kojima M; Okano M; Hashimoto Y; Saji S; Ohtake T; Chiba H
Breast Cancer Res; 2023 Apr; 25(1):41. PubMed ID: 37059993
[TBL] [Abstract][Full Text] [Related]
16. Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.
Toma MI; Erdmann K; Diezel M; Meinhardt M; Zastrow S; Fuessel S; Wirth MP; Baretton GB
PLoS One; 2014; 9(7):e102262. PubMed ID: 25025847
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.
D'Souza T; Indig FE; Morin PJ
Exp Cell Res; 2007 Sep; 313(15):3364-75. PubMed ID: 17678893
[TBL] [Abstract][Full Text] [Related]
18. Hypertonic stress increases claudin-4 expression and tight junction integrity in association with MUPP1 in IMCD3 cells.
Lanaspa MA; Andres-Hernando A; Rivard CJ; Dai Y; Berl T
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15797-802. PubMed ID: 18840681
[TBL] [Abstract][Full Text] [Related]
19. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
Wykosky J; Gibo DM; Stanton C; Debinski W
Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.
Gao Z; Han X; Zhu Y; Zhang H; Tian R; Wang Z; Cui Y; Wang Z; Niu R; Zhang F
Cell Death Dis; 2021 Apr; 12(5):414. PubMed ID: 33879771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
